Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maeve Herlihy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|June 27, 2024
Recurrent rash and orogenital ulcersMaeve Herlihy, Muriel Sadlier
Clinical and Experimental Dermatology|March 27, 2026
Cost Differences Between Psoriasis Biologics: Implications for the Irish High Tech SchemeOlwyn Conlon, Maeve Herlihy, Clare Harnett
Clinical and Experimental Dermatology|January 3, 2025
A rapidly enlarging axillary noduleMaeve Herlihy, Shane Brennan, Sinead Field
Clinical and Experimental Dermatology|November 7, 2023
Olanzapine-induced progressive facial oedema mimicking Morbihan diseaseMaeve Herlihy, Eimaer Duff, Muriel Sadlier
Clinical and Experimental Dermatology|June 24, 2024
Sexual dysfunction associated with isotretinoin treatment: a survey of the experiences of UK and Irish dermatologists and their approach to counselling and monitoringMaeve Herlihy, Paula Beatty, Sinead Field
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2024
Trending on TikTok: An analysis of melanotan content on social mediaMaeve Herlihy, Stephanie Bowe, Kashif Ahmad
Clinical and Experimental Dermatology|April 11, 2026
Refusal of melanoma treatment: respecting autonomy without abandoning careOlwyn Conlon, Maeve Herlihy, Siona Ni Raghallaigh
Clinical and Experimental Dermatology|January 10, 2024
Refugee healthcare: managing a chronic inflammatory skin condition through wartime and displacementMaeve Herlihy, Eimear Duff, Tetyana IInytska, et al.
Gut Microbes|February 9, 2018
Tumour-associated and non-tumour-associated microbiota: AddendumBurkhardt Flemer, Maeve Herlihy, Micheal O'Riordain, et al.
Clinical and Experimental Dermatology|July 6, 2026
Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanomaOlwyn Conlon, Maeve Herlihy, Yasmine Safta, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|June 27, 2024
Recurrent rash and orogenital ulcersMaeve Herlihy, Muriel Sadlier
Clinical and Experimental Dermatology|March 27, 2026
Cost Differences Between Psoriasis Biologics: Implications for the Irish High Tech SchemeOlwyn Conlon, Maeve Herlihy, Clare Harnett
Clinical and Experimental Dermatology|January 3, 2025
A rapidly enlarging axillary noduleMaeve Herlihy, Shane Brennan, Sinead Field
Clinical and Experimental Dermatology|November 7, 2023
Olanzapine-induced progressive facial oedema mimicking Morbihan diseaseMaeve Herlihy, Eimaer Duff, Muriel Sadlier
Clinical and Experimental Dermatology|June 24, 2024
Sexual dysfunction associated with isotretinoin treatment: a survey of the experiences of UK and Irish dermatologists and their approach to counselling and monitoringMaeve Herlihy, Paula Beatty, Sinead Field
Journal of the European Academy of Dermatology and Venereology : JEADV|August 16, 2024
Trending on TikTok: An analysis of melanotan content on social mediaMaeve Herlihy, Stephanie Bowe, Kashif Ahmad
Clinical and Experimental Dermatology|April 11, 2026
Refusal of melanoma treatment: respecting autonomy without abandoning careOlwyn Conlon, Maeve Herlihy, Siona Ni Raghallaigh
Clinical and Experimental Dermatology|January 10, 2024
Refugee healthcare: managing a chronic inflammatory skin condition through wartime and displacementMaeve Herlihy, Eimear Duff, Tetyana IInytska, et al.
Gut Microbes|February 9, 2018
Tumour-associated and non-tumour-associated microbiota: AddendumBurkhardt Flemer, Maeve Herlihy, Micheal O'Riordain, et al.
Clinical and Experimental Dermatology|July 6, 2026
Guselkumab for checkpoint inhibitor-exacerbated psoriasis in a patient with metastatic melanomaOlwyn Conlon, Maeve Herlihy, Yasmine Safta, et al.
Pageof 1